Jean-Claude Laborde

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA.

Medtronic CoreValve LLC develops transcatheter technologies for failing aortic heart valves. Its proprietary ReValving System allows both percutaneous (PAVR) and transapical aortic valve replacement (TAVR) and is intended to provide an alternative to open-heart surgery. The company was founded by Jacques Seguin in 2001 and is located in Irvine, CA.

Claret Medical, Inc. develops a cerebral protection technology designed to protect patients from the risk of stroke during left heart procedures and vascular interventions. It focuses on addressing the problem of stroke during transcatheter aortic valve replacement (TAVR), a significant unmet clinical need. The company was founded by Farhad Khosravi and Randy Lashinski in 2009 and is headquartered in Santa Rosa, CA.

Ernst & Young LLP engages in the provision of accounting services. The company was founded on April 6, 2001 and is headquartered in London, the United Kingdom.

VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel.

Vessl, Inc. engages in manufacturing soft drinks. It offers peach ginger black tea, pomegranate acai white tea, unsweetened black tea, citrus mint green tea, and recovery formula. The company was founded by Walter Apodaca and Don Park on February 10, 2014 and is headquartered in Tempe, AZ.

FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium.

Atrius Ltd. operates a healthcare center. The company is based in Ledbury, UK. The British company was founded in 2003 by William N. Starling, who has been the CEO since 2003.

Aegis Surgical Ltd. develops healthcare equipment for the treatment of symptomatic aortic stenosis. The company was founded by William N. Starling Jr. and is headquartered in Dublin, Ireland.

Protembis GmbH develops and manufactures medical devices for surgical heart procedures. Its device ProtEmbo is intended to protect patients from the risk of suffering a stroke during these procedures. The company was founded by Karl von Mangoldt and Conrad Rasmus in 2013 and is headquartered in Hamburg, Germany.

SoundBite Medical Solutions Inc. offers medical devices. It develops and commercializes proprietary shockwave device and generator technology. The company was founded by Steve Arless, Martin Brouillette, Louis-Philippe Riel and Steven Dion and is headquartered in Montreal, Canada.

ARUHIS Ventures GmbH provides investment services. The private company is based in Oberhaching, Germany. The German company was founded in 2013. The CEO is Frank Gabriel Groenewegen.

InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy.

Croivalve Ltd. develops medical device for treatment of tricuspid regurgitation. The company was founded by Lucy O'Keeffe and Martin Quinn in 2016 and is headquartered in Dublin, Ireland.

Moray Medical is a company that aims to revolutionize catheter technology by offering physicians a robotic catheter-based approach to an otherwise challenging and traumatic operation. The company is based in Mountain View, CA. Moray Medical's robotic system provides physicians with the dexterity and precision needed to treat hundreds of thousands of patients who are too frail to survive the trauma of conventional surgery. The company was founded by Keith Phillip Laby and Mark Barrish, with Mark Barrish serving as the CEO since incorporation.